Fresh From the Bench: Latest Precedential Patent Case
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.

CASE OF THE WEEK
Volvo Penta of the Americas, LLC v. Brunswick Corp., Appeal No. 2022-1765 (Fed. Cir. Aug. 24, 2023)
In its only precedential patent case of the week, the Federal Circuit held the Patent Trial and Appeal Board erred in finding a boat propeller system patent invalid as obvious. The Federal Circuit’s decision is an unusual opinion that found error in the PTAB’s consideration of objective indicia in the obviousness analysis. It is an example of the type of case where there may be a prima facie case of obviousness, with all factors satisfied, but with such strong real-world evidence of nonobviousness that those factors may inform the proper disposition of the case.

The patent concerns boat motors. Boat motors are characterized as outboard (i.e., an external engine on the stern of the boat), inboard (i.e., the engine and transmission are mounted in the hull, and a propeller shaft extends through the bottom of the hull), and “inboard/outboard,” wherein the engine is in the hull, but the drive unit is mounted outside the hull, typically on the stern. Such a configuration is also called a “stern drive” configuration.
Editors:
Nika Aldrich, IP Litigation Group Leader, Schwabe, Williamson & Wyatt, P.C.
Jason A. Wrubleski, Shareholder
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…